Discordant quantitative detection of putative biomarkers in nodal micrometastases of colorectal cancer: Biological and clinical implications

Journal of Clinical Pathology

Volumn 58, Issue 8, 2005, Pages 839-844

  Kong, S L ^a   Salto Tellez, M ^b   Leong, A P K ^b   Chan, Y H ^c   Koay, E S C ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c Clinical Trials and Epidemiology Research Unit   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 20; GUANYLATE CYCLASE; TUMOR MARKER;

ANTIGEN EXPRESSION; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; CRYOPRESERVATION; GENE EXPRESSION; GUANYLATE CYCLASE; HUMANS; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; LYMPHATIC METASTASIS; NEOPLASM STAGING; PARAFFIN EMBEDDING; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 23444451590     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.023853     Document Type: Article

References (32)

1. Toribara NW, Sleisenger MH. Screening for colorectal cancer. N Engl J Med 1995;332:861-7.
2. Jessup JM, McGinnis LS, Steele GDJ, et al. The National Cancer Data Base: report on colon cancer. Cancer 1996;78:918-26.
3. Lindblom A. Improved tumor staging in colorectal cancer [editorial]. N Engl J Med 1998;339:264-5.
4. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998;339:223-8.
5. Lassmann S, Bauer M, Soong R, et al. Quantification of CK20 gene and protein expression in colorectal cancer by RT-PCR and immunohistochemistry reveals inter- and intratumour heterogeneity. J Pathol 2002;198:198-206.
6. Gardner B, Feldman J. Are positive axillary nodes in breast cancer markers for incurable disease [discussion]? Ann Surg 1993;218:270-5.
7. Salto-Tellez M, Kong SL, Leong APK, et al. Intrinsic variability in the detection of micrometastases in lymph nodes for re-staging of colorectal cancer: effect of individual markers and tissue sample. Eur J Cancer 2003;39:1234-41.
8. Martell M, Gomez J, Esteban JI, et al. High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA. J Clin Microbiol 1999;37:327-32.
9. Nakao M, Janssen JW, Flohr T, et al. Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology. Cancer Res 2000;60:3281-9.
10. Mitas M, Mikhitarian K, Walters C, et al. Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int J Cancer 2001;93:162-71.
11. Northover J. The use of prognostic markers in surgery for colorectal cancer. Eur J Cancer 1995;31A:1207-9.
12. Moll R, Zimbelmann R, Goldschmidt MD, et al. The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas. Differentiation 1993;53:75-93.
13. Gyles CL. Escherichia coli cytotoxins and enterotoxins. Can J Microbiol 1992;38:734-46.
14. Carrithers SL, Parkinson SJ, Goldstein S, et al. Escherichia coli heat-stable toxin receptors in human colonic tumors. Gastroenterology 1994;107:1653-61.
15. Evans H, Sillibourne J. Detection of the Bcr-Abl gene in CML/ALL patients. Promega Notes Magazine 1996;57:21-3.
16. Gerhard M, Juhl H, Kalthoff H, et al. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 1994;12:725-9.
17. Funaki NO, Tanaka J, Ohshio G, et al. Cytokeratin 20 mRNA in peripheral venous blood of colorectal carcinoma patients. Br J Cancer 1998;77:1327-32.
18. Carrithers SL, Barber MT, Biswas S, et al. Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues. Proc Natl Acad Sci U S A 1996;93:14827-32.
19. Guan RJ, Van Dam J. Molecular detection of micrometastases: science on stage [review]. Am J Gastroenterol 1999;94:3062-4.
20. Mori M, Mimori K, Inoue H, et al. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 1995;55:3417-20.
21. Noguchi S, Aihara T, Motomura K, et al. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse-transcriptase polymerase chain reaction. Am J Pathol 1996;148:649-56.
22. Futumura M, Takagi Y, Koumura H, et al. Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptase-polymerase chain reactions for carcinoembryonic antigen and cytokeratin 20. J Surg Oncol 1998;68:34-40.
23. Datta YH, Adams PT, Drobyski WR, et al. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 1994;12:475-82.
24. Bostick PJ, Chatterjee S, Chi DD, et al. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 1998;16:2632-40.
25. Merrie AE, Yun K, Gunn J, et al. Analysis of potential markers for detection of submicroscopic lymph node metastases in breast cancer. Br J Cancer 1999;80:2019-24.
26. Jung R, Petersen K, Krüger W, et al. Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes. Br J Cancer 1999;81:870-3.
27. Champelovier P, Mongelard F, Seigneurin D. CK20 gene expression: technical limits for the detection of circulating tumor cells. Anticancer Res 1999;19:2073-8.
28. Waldman SA, Cagir B, Rakinic J, et al. Use of guanylyl cyclase C for detecting micrometastases in lymph nodes of patients with colon cancer. Dis Colon Rectum 1998;41:310-15.
29. Cagir B, Gelmann A, Park J, et al. Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer. Ann Intern Med 1999;131:805-12.
30. Godfrey TE, Raja S, Finkelstein SD, et al. Prognostic value of quantitative reverse-transcription-polymerase chain reaction in lymph node-negative esophageal cancer patients. Clin Cancer Res 2001;7:4041-8.
31. Raja S, El-Hefnawy T, Kelly LA, et al. Temperature-controlled primer limit for multiplexing of rapid, quantitative reverse transcription-PCR assays: application to intraoperative cancer diagnostics. Clin Chem 2002;48:1329-37.
32. Evron E, Dooley WC, Umbricht CB, et al. Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR. Lancet 2001;357:1335-6.